Statistics
Publications
16
Citations
8.1K
H-Index
15
Active since
1999
Kevin M. Marks is an author at Agios Pharmaceuticals (United States) specializing in molecular oncology, oncology, and medicine.
Publications per year
1999–2022
16
16
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4.1K citations · Full text
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato, Kevin M. Marks, Yoav D. Shaul et al. · Nature · 2011 · 1.7K citations · Full text
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2010 · 596 citations
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon, Michael J. Cameron, Phong Quang et al. · Cell Reports · 2016 · 447 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 16